Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · Real-Time Price · USD
0.192
-0.010 (-5.14%)
At close: Oct 29, 2024, 4:00 PM
0.196
+0.004 (2.14%)
After-hours: Oct 29, 2024, 6:31 PM EDT
Novo Integrated Sciences Revenue
Novo Integrated Sciences had revenue of $3.15M in the quarter ending May 31, 2024, a decrease of -4.28%. This brings the company's revenue in the last twelve months to $13.52M, up 1,102.98% year-over-year. In the fiscal year ending August 31, 2023, Novo Integrated Sciences had annual revenue of $12.57M with 7.11% growth.
Revenue (ttm)
$13.52M
Revenue Growth
+1,102.98%
P/S Ratio
0.24
Revenue / Employee
$58,769
Employees
230
Market Cap
3.65M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nuwellis | 9.01M |
Genetic Technologies | 6.45M |
Petros Pharmaceuticals | 4.12M |
Fresh2 Group | 2.34M |
Azitra | 408.20K |
Biodexa Pharmaceuticals | 104.90K |
NVOS News
- 3 months ago - Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results - Business Wire
- 3 months ago - What's Going On With Novo Integrated Sciences Stock On Friday? - Benzinga
- 3 months ago - Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program - Business Wire
- 4 months ago - Novo Integrated Sciences: A Coil Spring Ready To Explode - Seeking Alpha
- 4 months ago - Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program - Business Wire
- 5 months ago - Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million - Business Wire
- 5 months ago - Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products - Business Wire
- 5 months ago - Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note - Business Wire